Bibliography

1

J. L. Boxerman, L. M. Hamberg, B. R. Rosen et al.
``MR contrast due to intravascular magnetic susceptibility perturbations.''
Magn. Reson. Med. 34, pp. 555-566, 1995.

2

W. H. Perman, M. H. Gado, K. B. Larson et al.
``Simultaneous MR acquisition of arterial and brain signal-time curves.''
Magn. Reson. Med. 28, pp. 74-83, 1992.

3

J. C. de la Torre & G. B. Stefano.
``Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide.''
Brain Res. Rev. 34, pp. 119-136, 2000.

4

E. Farkas & P. G. M. Luiten.
``Cerebral microvascular pathology in aging and Alzheimer's disease.''
Prog. Neurobiol. 64, pp. 575-611, 2001.

5

M. A. Brown & R. C. Semelka.
MRI Basic Principles and Applications.
John Wiley and Sons, Inc, New Jersey, third edition, 2003.

6

S. Webb.
The Physics of Medical Imaging.
Medical Science Series. Adam Hilger, Bristol, Philadelphia and New York, 1988.

7

J. M. S. Hutchinson.
``Spin warp data acquisition.''
In I. R. Young (editor), Methods in Biomedical Magnetic Resonance Imaging and Spectroscopy, pp. 216-222. John Wiley and Sons Ltd, 2000.

8

L. E. Crooks.
``Image formation methods.''
In I. R. Young (editor), Methods in Biomedical Magnetic Resonance Imaging and Spectroscopy, pp. 205-216. John Wiley and Sons Ltd, 2000.

9

P. Mansfield.
``Echo-planar imaging.''
In I. R. Young (editor), Methods in Biomedical Magnetic Resonance Imaging and Spectroscopy, pp. 265-270. John Wiley and Sons Ltd, 2000.

10

A. G. Sorensen, A. L. Tievsky, L. Ostergaard et al.
``Contrast agents in functional MR imaging.''
J. Magn. Reson. Imaging 7, pp. 47-55, 1997.

11

B. R. Rosen, J. W. Belliveau, B. R. Buchbinder et al.
``Contrast agents and cerebral hemodynamics.''
Magn. Reson. Med. 19(2), pp. 285-292, 1991.

12

O. Speck, L. Chang, M. DeSilva et al.
``Perfusion MRI of the human brain with dynamic susceptibility contrast: Gradient-echo versus spin-echo techniques.''
J. Magn. Reson. Imaging 12, pp. 381-387, 2000.

13

J. R. Marstrand, E. Rostrup, S. Rosenbaum et al.
``Cerebral hemodynamic changes measured by gradient-echo or spin-echo bolus tracking and its correlation to changes in ICA blood flow measured by phase-mapping MRI.''
J. Magn. Reson. Imaging 14, pp. 391-400, 2001.

14

C. Z. Simonsen, L. Ostergaard, D. F. Smith et al.
``Comparison of gradient- and spin-echo imaging: CBF, CBV and MTT measurements by bolus tracking.''
J. Magn. Reson. Imaging 12, pp. 411-416, 2000.

15

G. Liu, G. Sobering, J. Duyn et al.
``A functional MRI technique combining principles of echo-shifting with a train of observations (PRESTO).''
Magn. Reson. Med. 30, pp. 764-768, 1993.

16

C. Moonen, G. Liu, P. V. Gelderen et al.
``A fast gradient-recalled MRI technique with increased sensitivity to dynamic susceptibility effects.''
Magn. Reson. Med. 26, pp. 184-189, 1992.

17

P. van Gelderen, C. Grandin, J. R. Petrella et al.
``Rapid three-dimensional MR imaging method for tracking a bolus of contrast agent through the brain.''
Radiology 216, pp. 603-608, 2000.

18

M. Pedersen, M. Klarhofer, S. Christensen et al.
``Quantitative cerebral perfusion using the PRESTO acquisition scheme.''
J. Magn. Reson. Imaging 20, pp. 930-940, 2004.

19

M. Forsting, W. Reith, S. Heiland et al.
``MR-perfusion imaging in cerebrovascular disease: from experimental research to clinical application.''
Advances in MRI Contrast 3, pp. 60-69, 1995.

20

C. B. Grandin.
``Assessment of brain perfusion with MRI: methodology and application to acute stroke.''
Neuroradiology 45, pp. 755-766, 2003.

21

M. Wiart, Y. Berthezene, P. Adeleine et al.
``Vasodilatory response of border zones to acetazolamide before and after endarterectomy.''
Stroke 31, pp. 1561-1565, 2000.

22

D. J. Lythgoe, L. Ostergaard, S. C. R. Williams et al.
``Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging.''
Magn. Reson. Imaging 18, pp. 1-11, 2000.

23

P. Mukherjee, H. C. Kang, T. O. Videen et al.
``Measurement of cerebral blood flow in chronic carotid occlusive disease: Comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography.''
Am. J. Neuroradiol. 24, pp. 862-871, 2003.

24

F. Calamante, V. Ganesan, F. J. Kirkham et al.
``MR perfusion imaging in Moyamoya syndrome - potential implications for clinical evaluation of occlusive cerebrovascular disease.''
Stroke 32, pp. 2810-2816, 2001.

25

J. E. Perthen, F. Calamante, D. G. Gadian et al.
``Is quantification of bolus tracking MRI reliable without deconvolution.''
Magn. Reson. Med. 47, pp. 61-67, 2002.

26

G. N. Stewart.
``Researches on the circulation time in organs and on the influences which affect it. Parts I-III.''
J. Physiol. 15, pp. 1-45, 1894.

27

R. M. Weisskoff, D. Chesler, J. L. Boxerman et al.
``Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time?''
Magn. Reson. Med. 29(4), pp. 553-559, Apr 1993.

28

K. A. Rempp, G. Brix, F. Wenz et al.
``Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging.''
Radiology 193(3), pp. 637-641, Dec 1994.

29

K. L. Zierler.
``Theoretical basis of indicator-dilution methods for measuring flow and volume.''
Circ. Res. 10, pp. 393-407, 1962.

30

L. Ostergaard, A. G. Sorensen, K. K. Kwong et al.
``High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.''
Magn. Reson. Med. 36(5), pp. 726-736, Nov 1996.

31

A. M. Smith, C. B. Grandin, T. Duprez et al.
``Whole brain quantitative CBF and CBV measurements using MRI bolus tracking: Comparison of methodologies.''
Magn. Reson. Med. 43(4), pp. 559-564, Apr 2000.

32

R. Wirestam, L. Andersson, L. Ostergaard et al.
``Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques.''
Magn. Reson. Med. 43, pp. 691-700, 2000.

33

L. Ostergaard, R. M. Weisskoff, D. A. Chesler et al.
``High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis.''
Magn. Reson. Med. 36(5), pp. 715-725, Nov 1996.

34

F. Calamante, D. G. Gadian & A. Connelly.
``Quantification of bolus-tracking MRI: Improved characterisation of the tissue residue function using Tikhonov regularization.''
Magn. Reson. Med. 50, pp. 1237-1247, 2003.

35

E. P. A. Vonken, F. J. Beekman, C. J. G. Bakker et al.
``Maximum likelihood estimation of cerebral blood flow in dynamic susceptibility contrast MRI.''
Magn. Reson. Med. 41, pp. 343-350, 1999.

36

M. J. P. van Osch, E. P. A. Vonken, C. J. G. Bakker et al.
``Correcting partial volume artefacts of the arterial input function in quantitative cerebral perfusion MRI.''
Magn. Reson. Med. 45, pp. 477-485, 2001.

37

L. Ostergaard, P. Johannsen, P. Host-Poulsen et al.
``Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: Comparison with $[^{15}O]$H$_2$O positron emission tomography in humans.''
J. Cereb. Blood F. Met. 18(9), pp. 935-940, Sep 1998.

38

F. Calamante, D. G. Gadian & A. Connelly.
``Delay and dispersion effects in dynamic susceptibility contrast MRI: Simulations using singular value decomposition.''
Magn. Reson. Med. 44(3), pp. 464-473, Sep 2000.

39

L. Ostergaard, D. A. Chesler, R. M. Weisskoff et al.
``Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data.''
J. Cereb. Blood F. Met. 19(6), pp. 690-699, Jun 1999.

40

K. Kroll, N. Wilke, H. M. Jerosch et al.
``Modeling regional myocardial flows from residue functions of an intravascular indicator.''
Am. J. Physiol. 1996.

41

R. F. Schmidt & G. Thews.
Human Physiology.
Springer Verlag, Berlin, second edition, 1989.

42

L. Wei, L. Otsuka, V. Acuff et al.
``The velocities of red cell and plasma flows through parenchymal microvessels of rat brain are decreased by pentobarbitol.''
J. Cereb. Blood F. Met. 13, pp. 487-497, 1993.

43

W. G. Schreiber, F. Guckel, P. Stritzke et al.
``Cerebral blood flow and cerebrovascular reserve capacity: Estimation by dynamic magnetic resonance imaging.''
J. Cereb. Blood F. Met. 18(10), pp. 1143-1156, Oct 1998.

44

S. Flacke, H. Urbach, P. J. M. Folkers et al.
``Ultra-fast three-dimensional MR perfusion imaging of the entire brain in acute stroke assessment.''
J. Magn. Reson. Imaging 11, pp. 250-259, 2000.

45

F. Wenz, K. Rempp, G. Brix et al.
``Age dependency of the regional cerebral blood volume (rCBV) measured with dynamic susceptibility contrast MR imaging (DSC).''
Magn. Reson. Imaging 14(2), pp. 157-162, 1996.

46

H. S. Markus, D. J. Lythgoe, L. Ostergaard et al.
``Reduced cerebral blood flow in white matter in ischaemic leukaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI.''
J. Neurol. Neurosur. Ps. 69(1), pp. 48-53, Jul 2000.

47

J. Hatazawa, E. Shimosegawa, H. Toyoshima et al.
``Cerebral blood volume in acute brain infarction - a combined study with dynamic susceptibility contrast MRI and Tc-99m-HMPAO-SPECT.''
Stroke 30(4), pp. 800-806, Apr 1999.

48

T. Hagen, K. Bartylla & U. Piepgras.
``Correlation of regional cerebral blood flow measured by stable xenon CT and perfusion MRI.''
J. Comp. Assist. Tomo. 3(2), pp. 257-264, Mar-Apr 1999.

49

M. D. Miller, C. F. Paradis, P. R. Houck et al.
``Rating chronic medical illness burden in geropsychiatric practice and reasearch: application of Cumulative Illness Rating Scale.''
Psychiat. Res 41, pp. 237-248, 1992.

50

R. C. Baldwin & J. O'Brien.
``Vascular basis of late-onset depressive disorder.''
Brit. J. Psychiatry 180, pp. 157-160, 2002.

51

R. Ramasubbu.
``Relationship between depression and cerebrovascular disease: conceptual issues.''
J. Aff. Dis. 57, pp. 1-11, 2000.

52

K. R. R. Krishnan, J. C. Hays & D. G. Blazer.
``MRI-defined vascular depression.''
Am. J. Psychiatry 154, pp. 497-501, 1997.

53

F. E. Taragano, R. Allegri, A. Vicario et al.
``A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of `vascular depression'.''
Int. J. Geriatr. Psychiatry 16, pp. 254-260, 2001.

54

A. J. Thomas, I. N. Ferrier, R. N. Kalaria et al.
``A neuropathological study of vascular factors in late-life depression.''
J. Neurol. Neurosur. Ps. 70, pp. 83-87, 2001.

55

H. Tiemeier, S. L. M. Bakker, A. Hofman et al.
``Cerebral haemodynamics and depression in the elderly.''
J. Neurol. Neurosur. Ps. 73, pp. 34-39, 2002.

56

J. H. Naish, R. C. Baldwin, S. Jeffries et al.
``Analysis of cerebral flow in patients with late life depression.''
In Proc. MIUA, volume 6, pp. 41-44. BMVA, 2001.

57

I. Hickie, E. Scott, P. Mitchell et al.
``Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression.''
Biol. Psychiatry 37, pp. 151-160, 1995.

58

I. Hickie & E. Scott.
``Late-onset depressive disorders: a preventable variant of cerebrovascular disease.''
Psychol. Med. 28, pp. 1007-1013, 1998.

59

S. Dahabra, C. H. Ashton, M. Bahrainian et al.
``Structural and functional abnormalities in elderly patients clinically recovered from early- and late-onset depression.''
Biol. Psychiatry 44, pp. 34-46, 1998.

60

A. Kumar, W. Bilker, Z. Jin et al.
``Atrophy and high intensity lesions: Complementary neurobiological mechanisms in late-life depression.''
Neuropsychopharmacology 22, pp. 264-274, 2000.

61

D. C. Steffens, K. R. R. Krishnan, C. Crump et al.
``Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study.''
Stroke 33, pp. 1636-1644, 2002.

62

A. Kumar, Z. Jin, W. Bilker et al.
``Late-onset minor and major depression: Early evidence for common neuroanatomical substrates detected by using MRI.''
Proc. Nat. Acad. Sci. USA 95(13), pp. 7654-7658, June 1998.

63

A. Rigaud, F. Latour, F. Moulin et al.
``Apolipoprotein E $\epsilon$4 allele and clinically defined vascular depression.''
Arch. Gen. Psychiatry 59, pp. 290-291, March 2002.

64

G. W. Small, P. V. Rabins, P. P. Barry et al.
``Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.''
J. Am. Med. Ass. 278(16), pp. 1363-1379, 1997.

65

A. Varrone, S. Pappata, C. Caraco et al.
``Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.''
Eur. J. Nucl. Med. 29(11), pp. 1447-1454, 2002.

66

W. B. Matthews.
``Dementia.''
In D. J. Weatherall, J. G. G. Ledingham & D. A. Warrell (editors), Oxford Textbook of Medicine, volume 2, pp. 21.42-21.46. Oxford medical publishers, 1987.

67

I. Goethals, C. V. D. Wiele, D. Slosman et al.
``Brain SPET perfusion in early Alzheimer's disease: where to look?''
Eur. J. Nucl. Med. 29(8), pp. 975-978, 2002.

68

W. Jagust, R. Thisted, M. D. Devous et al.
``SPECT perfusion imaging in the diagnosis of Alzheimer's disease - a clinical-pathologic study.''
Neurol. 56, pp. 950-956, 2001.

69

M. B. Pepys.
``Amyloidosis.''
In D. J. Weatherall, J. G. G. Ledingham & D. A. Warrell (editors), Oxford Textbook of Medicine, volume 1, pp. 9.145-9.157. Oxford Medical Publishers, 1987.

70

G. W. Small, S. T. Chen, S. Komo et al.
``Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele.''
Am. J. Psychiatry 156, pp. 1035-1038, 1999.

71

J. Hardy.
``Amyloid, the presenilins and Alzheimer's disease.''
Trend. Neurosci. 20(4), pp. 154-159, 1997.

72

B. D. Strooper.
``Aph-1, Pen-2, and Nicastrin with Presenilin generate an active $\gamma$-secretase complex.''
Neuron 38, pp. 9-12, 2003.

73

M. Baron.
``An overview of the Notch signalling pathway.''
Sem. Cell Develop. Biol. 14, pp. 113-119, 2003.

74

K. Hsiao, P. Chapman, S. Nilsen et al.
``Correlative memory deficits, elevation and amyloid plaques in transgenic mice.''
Stroke 247(5284), pp. 99-103, October 1996.

75

M. A. Smith, K. L. Drew, A. Nunomura et al.
``Amyloid-$\beta$, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?''
Neurochem. Int. 40, pp. 527-531, 2002.

76

W. J. Lukiw & N. G. Bazan.
``Neuroinflammatory signaling upregulation in Alzheimer's disease.''
Neurochem. Res. 25(9/10), pp. 1173-1184, 2000.

77

J. S. Fleming, P. M. Kemp, L. Bolt et al.
``Measurement of cerebral perfusion volume and $^{99m}$Tc-HMPAO uptake using SPECT in controls and patients with Alzheimer's disease.''
Nucl. Med. Comm 23, pp. 1057-1064, 2002.

78

J. Ashburner & K. J. Friston.
``Voxel-based morphometry - the methods.''
Neuroimage 11, pp. 805-821, 2000.

79

F. L. Bookstein.
````Voxel-based morphometry'' should not be used with imperfectly registered images.''
Neuroimage 14, pp. 1454-1462, 2001.

80

W. R. Crum, L. D. Griffin, D. L. G. Hill et al.
``Zen and the art of medical image registration: correspondence, homology and quality.''
Neuroimage 20(3), pp. 1425-1437, 2003.

81

C. Davatzikos.
``Why voxel-based morphometric analysis should be used with great caution when characterising group differences.''
Neuroimage 23(1), pp. 17-20, Sept 2004.

82

K. Lobotesis, J. D. Fenwick, A. Phipps et al.
``Occipital hypoperfusion on SPECT in dementia with Lewy Bodies but not AD.''
Neurol. 56, pp. 643-649, 2001.

83

A. Cappa, M. L. Calcagni, G. Villa et al.
``Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment.''
J. Neurol. Neurosur. Ps. 70, pp. 22-27, 2001.

84

M. Benoit, P. M. Koulibaly, O. Migneco et al.
``Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis.''
Psychiat. Res-Neuroim. 114, pp. 103-111, 2002.

85

P. H. Scheltens, F. Barkhof, J. Valk et al.
``White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease.''
Brain 115, pp. 735-748, 1992.

86

D. Mungas, B. R. Reed, W. J. Jagust et al.
``Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease.''
Neurol. 59, pp. 867-873, 2002.

87

K. L. Double, G. M. Halliday, J. J. Krill et al.
``Topography of brain atrophy during normal aging and Alzheimer's disease.''
Neurobiol. Aging 17(4), pp. 513-521, 1996.

88

S. W. Small.
``What we need to know about age related memory loss.''
Brit. Med. J 324, pp. 1502-1505, 2002.

89

A. Burns & M. Zaudig.
``Mild cognitive impairment in older people.''
Lancet 360, pp. 1963-65, 2002.

90

R. C. Petersen, R. Doody, A. Kurtz et al.
``Current concepts in mild cognitive impairment.''
Arch. Neurol. 58, pp. 1985-1992, December 2001.

91

R. C. Petersen, G. E. Smith, S. C. Waring et al.
``Mild cognitive impairment - clinical characterization and outcome.''
Arch. Neurol. 56, pp. 303-308, March 1999.

92

C. A. de Jager, E. Milwain & M. Budge.
``Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests.''
Psychol. Med. 32, pp. 483-491, 2002.

93

A. F. Jorm, H. Christensen, A. E. Korten et al.
``Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7-8 years.''
Psychol. Med. 31, pp. 441-449, 2001.

94

T. Hanninen, M. Hallikainen, S. Tuomainen et al.
``Prevalence of mild cognitive impairment: a population-based study in elderly subjects.''
Acta Neurol. Scand. 106, pp. 148-154, 2002.

95

N. J. Kabani, J. G. Sled, A. Shuper et al.
``Regional magnetization transfer ratio changes in mild cognitive impairment.''
Magn. Reson. Med. 47, pp. 143-148, 2002.

96

N. A. Thacker, M. L. J. Scott, D. L. Buckley et al.
``A new method for the quantitative calculation of net blood flow using T2* susceptibility imaging.''
In Proc. ISMRM. Hawaii, 2002.

97

N. A. Thacker, M. L. J. Scott, A. J. Lacey et al.
``Accurate estimation of contrast arrival in T2* susceptibility contrast imaging.''
In Proc. ISMRM. Hawaii, 2002.

98

N. A. Thacker, M. L. J. Scott, C. Moonen et al.
``Quantitative estimation of blood velocity in T2* susceptibility perfusion.''
In Proc. ISMRM. Hawaii, 2002.

99

M. L. J. Scott, N. A. Thacker, A. J. Lacey et al.
``A novel method for cerebral blood flow calculation.''
In A. Houston & R. Zwiggelaar (editors), Proc. MIUA, volume 6, pp. 45-48. BMVC, July 2002.

100

M. L. J. Scott, N. A. Thacker & A. J. Lacey.
``Separating normal and disease groups using regional cerebral blood flow.''
In D. Barber (editor), Proc. MIUA, volume 7, pp. 17-20. BMVC, July 2003.

101

M. L. J. Scott, N. A. Thacker, P. A. Bromiley et al.
``Separating normal and disease groups using vascular territories.''
In European Congess of Radiology. March 2004.

102

N. A. Thacker, M. L. J. Scott & A. Jackson.
``Can dynamic susceptibility contrast magnetic resonance imaging perfusion data be analyzed using a model based on directional flow?''
J. Magn. Reson. Imaging 17(2), pp. 241-255, February 2003.

103

J. L. Boxerman, B. R. Rosen & R. M. Weisskoff.
``Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies.''
J. Magn. Reson. Imaging 7(3), pp. 528-537, May-Jun 1997.

104

R. Ellinger, C. Kremser, M. F. H. Schocke et al.
``The impact of peak saturation of the arterial input function on quantitative evaluation of dynamic susceptibility contrast-enhanced MR studies.''
J. Comp. Assist. Tomo. 24(6), pp. 942-948, 2000.

105

K. L. Li, X. P. Zhu, J. Waterton et al.
``Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors.''
J. Magn. Reson. Imaging 12, pp. 347-357, 2000.

106

H. Haroon.
First Pass Pharmacokinetic Modelling in Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Application in Human Oncology.
Ph.D. thesis, Division of Imaging Science and Biomedical Engineering, University of Manchester, 2005.

107

M. M. Bahn.
``A single step method for estimation of local cerebral blood volume from susceptibility contrast MRI.''
Magn. Reson. Med. 33(3), pp. 309-317, Mar 1995.

108

M. J. P. van Osch, E. P. A. Vonken, O. Wu et al.
``Model of the human vasculature for studying the influence of contrast injection speed on cerebral perfusion MRI.''
Magn. Reson. Med. 50, pp. 614-622, 2003.

109

M. Pokric, N. Thacker, M. L. J. Scott et al.
``Multi-dimensional medical image segmentation with partial voluming.''
In Proc. MIUA, pp. 77-81. 2001.

110

N. A. Thacker, F. J. Ahearne & P. I. Rockett.
``The Bhattacharryya metric as an absolute similarity measure for frequency coded data.''
Kybernetica 34(4), pp. 363-368, 1997.

111

N. A. Thacker & P. A. Bromiley.
``The effects of a square root transform on a Poisson distributed quantity.'', 2001.
Tina Memo 2001-010.

112

J. A. de Zwart, P. J. Ledden, P. Kellman et al.
``Design of a SENSE-optimized high-sensitivity MRI receive coil for brain imaging.''
Magn. Reson. Med. 47, pp. 1218-1227, 2002.

113

K. P. Pruessmann, M. Weiger, M. B. Scheidegger et al.
``SENSE: sensitivity encoding for fast MRI.''
Magn. Reson. Med. 42, pp. 952-962, 1999.

114

X. Golay, K. P. Pruessmann, M. Weiger et al.
``PRESTO-SENSE: and ultrafast whole-brain fMRI technique.''
Magn. Reson. Med. 43, pp. 779-786, 2000.

115

M. Klarhofer, B. Diharreguy, P. van Gelderen et al.
``A PRESTO-SENSE sequence with alternating partial-fourier encoding for rapid susceptibility-weighted 3D MRI time series.''
Magn. Reson. Med. 50, pp. 830-838, 2003.

116

P. C. Buijs, M. J. Krabbe-Hartkamp, E. E. de Lange et al.
``Effect of age on cerebral blood flow: Measurement with ungated two-dimensional phase-contrast MR angiography in 250 adults.''
Radiology 209, pp. 667-674, 1998.

117

H. Okazawa, H. Yamauchi, K. Sugimoto et al.
``Quantitative comparison of the bolus and steady-state methods for measurement of cerebral perfusion and oxygen metabolism: Positron emission study using $^15$O-gas and water.''
J. Cereb. Blood F. Met. 21, pp. 793-803, 2001.

118

M. Arigoni, S. Kneifel, J. Fandino et al.
``Simplified quantitative determination of cerebral perfusion reserve with H$_2 ^{15}$O PET and acetazolamide.''
Eur. J. Nucl. Med. 27(10), pp. 1557-1563, 2000.

119

H. Watabe, M. Itoh, V. Cunningham et al.
``Noninvasive quantification of rCBF using positron emission tomography.''
J. Cereb. Blood F. Met. 16(2), pp. 311-319, 1996.

120

F. Q. Ye, K. F. Berman, T. Ellmore et al.
``H$_2 ^{15}$O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans.''
Magn. Reson. Med. 44, pp. 450-456, 2000.

121

S. T. Francis, P. A. Gowland & R. W. Bowtell.
``Continuous saturation EPI with diffusion weighting at 3.0T.''
NMR Biomed. 12, pp. 440-450, 1999.

122

G. Kim & N. V. Tsekos.
``Perfusion imaging by a flow-sensitive alternating inversion recovery (Fair)technique: Application to functional brain imaging.''
Magn. Reson. Med. 37, pp. 425-435, 1997.

123

K. Murase, T. Inoue, H. Fujioka et al.
``An alternative approach to estimation of the brain perfusion index for measurement of cerebral blood flow using technetium-99m compounds.''
Eur. J. Nucl. Med. 26(10), pp. 1333-1339, 1999.

124

M. Kluytmans, J. van der Grond & M. A. Viergever.
``Gray matter and white matter perfusion imaging in patients with severe carotid artery lesions.''
Radiology 209, pp. 675-682, 1998.

125

W. Lin, A. Celik, C. Derdeyn et al.
``Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PET and MR study.''
J. Magn. Reson. Imaging 14, pp. 659-667, 2001.

126

M. Kluytmans, J. van der Grond, K. J. van Everdingen et al.
``Cerebral hemodynamics in relation to patterns of collateral flow.''
Stroke 30, pp. 1432-1439, 1999.

127

L. Tatu, T. Moulin, J. Bogousslavsky et al.
``Arterial territories of the human brain: Cerebral hemispheres.''
Neurol. 50(6), pp. 1699-1708, 1998.

128

E. Lang, M. Daffertshofer, A. Daffertshofer et al.
``Variability of vascular territory in stroke: pitfalls and failure of stroke pattern interpretation.''
Stroke 26(6), pp. 942-945, June 1995.

129

L. Tatu, T. Moulin, J. Bogousslavsky et al.
``Arterial territories of the human brain: Brainstem and cerebellum.''
Neurol. 47(5), pp. 1125-1135, 1996.

130

T. B. Moller & E. Reif.
Pocket Atlas of Cross-Sectional Anatomy CT and MRI, volume 1; Head, Neck, Spine and Joints.
Theime, 1994.

131

T. F. Cootes, A. Hill, C. J. Taylor et al.
``The use of active shape models for locating structures in medical images.''
Image Vision Comput. 12(6), pp. 355-366, 1994.

132

R. Baldwin, S. Jeffries, A. Jackson et al.
``Treatment response in late-life depression: relationship to neuropsychological, neuroradiological and vascular risk factors.''
Psychol. Med. 34, pp. 125-136, 2004.

133

P. Rabbitt, C. Lowe, N. Thacker et al.
``Gross age related changes in brain volume and in cerebral blood flow account for nearly all age related changes in information processing speed and other measures of cognitive function.''
Neuropsychology 2005.
Accepted for publication.

134

M. P. Marks, N. J. Pelc, M. R. Ross et al.
``Determination of cerebral blood flow with a phase-contrast cine MR imaging technique: evaluation of normal subjects and patients with arteriovenous malformations.''
Radiology 182, pp. 467-476, 1992.

135

A. J. Evans, F. Iwai, T. A. Grist et al.
``Magnetic resonance imaging of blood flow with a phase subtraction technique.''
Invest. Radiol. 28, pp. 109-115, 1993.

136

N. A. Thacker, A. R. Varma, D. Bathgate et al.
``Dementing disorders: Volumetric measurement of cerebrospinal fluid to distinguish normal from pathologic findings - feasibility study.''
Radiology 224(1), pp. 278-285, Jul 2002.

137

P. A. Bromiley, N. A. Thacker & A. Jackson.
``Trends in brain volume change with normal ageing.'', 2004.
Tina Memo 2004-002, www.tina-vision.net/memos/2004-002.pdf.

138

R Development Core Team.
R: A language and environment for statistical computing.
R Foundation for Statistical Computing, Vienna, Austria, 2004.
ISBN 3-900051-07-0.

139

J. Pallant.
SPSS Survival Manual: A Step By Step Guide to Data Analysis Using SPSS for Windows (Version 10).
Open University Press, 2001.

140

P. A. Bromiley, N. A. Thacker, M. L. J. Scott et al.
``Bayesian and non-Bayesian probabilistic models for image analysis.''
Image Vision Comput. 21, pp. 851-864, 2003.

141

J. Talairach & P. Tournoux.
Co-planar stereotaxic atlas of the human brain. 3-dimensional proportional system: An approach to cerebral imaging.
Thieme medical publishers, New York, 1988.

142

M. L. J. Scott.
``Critical values for the test of flatness of a histogram using the Bhattacharyya measure.'', 2004.
Tina Memo 2004-010.

143

N. A. Thacker & P. A. Bromiley.
``The equal variance domain: Issues surrounding the use of probability densities in algorithm design.'', 2004.
Tina Memo 2004-005.